Examining Recent Options Trends for Exact Sciences Stock
Recent Options Activity for Exact Sciences Corporation
Investors have recently exhibited a bullish attitude towards Exact Sciences (NASDAQ: EXAS). This increased activity is essential for retail traders to understand, as significant movements in stock options often indicate underlying shifts in market sentiment.
Monitoring the unfolding trends, our observation pointed to a surge in large trades that were visible in public options history today. We acknowledge that these trades might be attributed to institutional investors or individual traders with substantial capital. However, the sheer scale of the trading activity often signals that someone anticipates a significant change on the horizon for Exact Sciences.
Earlier today, the options scanner detected a total of nine different trades focusing on Exact Sciences. This volume is notably abnormal and merits interest.
Analyzing Market Sentiment
Looking closely at the activity, we noted that the trading sentiment among these large investors is somewhat divided, with approximately 44% taking a bullish position while 33% leaned bearish. Among the trades we investigated, there was a lone put option, amounting to $117,000, contrasted with eight calls totaling around $372,081.
Projected Price Movements for Exact Sciences
Based on our analysis of the volume and open interest associated with these options, it appears large stakeholders are forecasting potential price trajectories for Exact Sciences falling within the range of $55.0 to $85.0. This observation aligns with the activity registered over the past quarter.
Trade Volume and Open Interest Insights
Today’s trading landscape revealed that the average open interest for Exact Sciences options is around 1016.57, complemented by a total volume of 2,211.00. This data allows us to track which direction the market sentiment might shift towards in the near future.
Understanding Recent Options Trades
To delve further into the specifics of the trades, here's a summary of the significant options activity observed within the last month:
- Symbol: EXAS
- PUT/CALL: PUT
- Trade Type: TRADE
- Sentiment: BULLISH
- Expiration Date: 11/15/24
- Price: $4.3
- Total Trade Price: $117,000
- Volume: 300
- Open Interest: 10
- Symbol: EXAS
- PUT/CALL: CALL
- Trade Type: SWEEP
- Sentiment: BEARISH
- Expiration Date: 09/20/24
- Price: $3.0
- Total Trade Price: $59,000
- Volume: 1.1K
- Open Interest: 4.1K
All About Exact Sciences
Exact Sciences is a prominent player in the healthcare sector, specializing in innovative cancer screening and diagnostic testing solutions. The company's flagship product, Cologuard, serves as a noninvasive stool-based DNA test aimed at colorectal cancer screening. Additionally, Exact Sciences is active in precision oncology with Oncotype DX, delivering genomic tests that project cancer recurrence risks for breast and colon cancer, alongside OncoExTra, a liquid biopsy assessment for comprehensive genomic profiling.
Current Market Status of Exact Sciences
- Recent trading volumes for Exact Sciences have reached approximately 3,695,220 shares, with the stock price rising by 1.8%, landing at $66.72.
- The Relative Strength Index (RSI) suggests that EXAS may be nearing an overbought condition.
- Investors should note that the next earnings report is on the horizon, scheduled in about 44 days.
Analyst Opinions on Exact Sciences
Within the previous month, three analysts provided their insights regarding EXAS, establishing an average target price of about $78.33. Here’s a quick overview of their ratings:
- A Wells Fargo analyst downgraded their stance to Overweight with a target of $75.
- Canaccord Genuity has maintained a Buy rating, also targeting $75.
- Piper Sandler has sustained an Overweight rating, setting their target at $85.
Investing in options carries inherent risks compared to direct stock trading, but they also offer prospects for higher returns. Savvy options traders mitigate risks through daily education, strategically entering and exiting positions, and adhering to various market indicators.
Frequently Asked Questions
What is Exact Sciences Corporation known for?
Exact Sciences specializes in cancer screening and diagnostic tests, including the well-known Cologuard test for colorectal cancer screening.
What does recent options activity indicate about Exact Sciences?
Increased options activity often signifies potential market movement or anticipations, suggesting traders have insights into future developments for the company.
What was the recent stock trading volume for EXAS?
The recent trading volume for Exact Sciences was approximately 3,695,220 shares, indicating active trading and interest in the stock.
Who are the key analysts covering Exact Sciences?
The analysts from firms such as Wells Fargo, Canaccord Genuity, and Piper Sandler are among those providing insights and ratings for Exact Sciences.
Where can I find real-time options updates for Exact Sciences?
Real-time updates on options trades for Exact Sciences can be accessed through financial news services, trading platforms, and relevant market analysis tools.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Great Elm Group Welcomes Deloitte as New Auditor for Future Growth
- AgriForce Secures New Funding Agreement, Adjusts Executive Pay
- Equity Bancshares Declares Quarterly Cash Dividend for Shareholders
- InPoint Commercial Real Estate's Recent NAV Update and Insights
- OpenAI Establishes Independent Safety Committee for AI Oversight
- Kilroy Realty Announces Dividend Plans for Shareholders
- Ford Motor Company Investors Should Act Before Lead Deadline
- Leadership Transition at Starbucks: What Lies Ahead for SBUX?
- Future Growth of the Premium Chocolate Sector: Insights and Trends
- Squirrel Cayman Partners with HSPO for Strategic Merger
Recent Articles
- Analyzing Key Options Activities for RH in the Market
- Insightful Options Activity Signals Growth for TeraWulf
- State Street Enhances Community Support with New Deposits
- DraftKings Sees Positive Momentum with NFL Underdogs Performance
- Foghorn Therapeutics Sees Promising 9.5% Surge in Shares
- Empresa (EDN): Unlocking Potential and Fast Momentum
- BP Partners with ABS for Advanced Kaskida FPU Services
- Supporting Afghan Girls: A Call for Education Equality
- Crave Brothers' Exciting Fresh Sweep at World Dairy Expo
- Exploring Growth in Military Cybersecurity Market Trends
- Electrical Safety Made Easy at Ravenna Balloon A-Fair Event
- DisposeRx Sells Coaches vs Overdoses to Pennant for Growth
- Vicor Corporation Investors Urged to Act Before Deadline
- Crypto Market Predictions: Insights Ahead of Rate Decisions
- MacroGenics, Inc. Investors Urged for Legal Deadlines Awareness
- Class Action Filed Against Allarity Therapeutics: Key Insights
- Investing Alert: Join Class Action Against American Airlines
- Banijay Group Reports Recent Share Transactions and Insights
- Catalight Welcomes Dr. Bearss to Enhance Autism Care Solutions
- Kevin Fuller Takes the Helm as CMO at Nature's Sunshine
- How a Small Bitcoin Investment in 2019 Could Transform Your Wealth
- Investors Reminded of Class Action Deadline for FIVE Shares
- Lifecore Biomedical, Inc. Investors Urged to Take Action Now
- Urgent Alert for Arbor Realty Trust Investors: Know Your Rights
- Innovative STEM Program from RTX and Boys & Girls Clubs
- Lattice Semiconductor's New CEO Fuels Stock Surge
- UFP Industries Welcomes Stanley Elliott as Investor Relations Director
- Exploring Investment Opportunities in WisdomTree Cloud ETF
- Cleveland-Cliffs Advances Green Steel Project for Future Growth
- Understanding Market Psychology: Arm Holdings' Potential Support
- Analyzing Market Sentiment Surrounding Capital One Financial
- Understanding Recent Increases in Vision Marine's Short Interest
- Exploring BXP's Short Interest Trends and Market Implications
- Kentucky First Federal Bancorp Faces Economic Headwinds
- NewtekOne's Successful $75 Million Senior Notes Offering Boosts Growth
- MCA Expands Reach with Clear Talk Acquisition and Growth
- Gogo Inc. Stock Hits New Low: Prospects Amid Challenges
- Amazon Delivery Drivers Unite in New York for Union Rights
- Nature's Sunshine Appoints Kevin Fuller as Global CMO
- Celebrating Heroes of Military Medicine: Join the Tribute Soon
- Celebrating Leadership: Steve Jbara's Impact in G League
- Intel Secures $3 Billion for Crucial Chip Security Program
- Construction Partners Inc Sees Stock Surge to Record High
- CenterPoint Energy's Strategic Moves Amid Regulatory Challenges
- Focus Impact Acquisition Unit (FIACU) Reaches Record Stock Prices
- Smartsheet Achieves 52-Week High with Positive Financial Outlook
- Cleveland-Cliffs' Commitment to Sustainable Steel Innovation
- Argentina's Economic Challenges: Recession Continues Amid Reforms
- Carlyle Group Resumes IPO Plans for Nouryon Chemical Business
- Brady Corp's Stock Performance Amid Executive Transactions